Faricimab Injection

DRUG3 trials

Sponsors

University of Colorado, Denver, Faculty Hospital Kralovske Vinohrady, University of Baghdad

Conditions

Age-Related Macular DegenerationDiabetic RetinopathyVitreous Hemorrhage Due to Diabetes MellitusWet Age-related Macular Degeneration

Phase 2

Intravitreal Faricimab in Patients With Refractory Macular Edema

CompletedNCT07093385

University of BaghdadAge-Related Macular Degeneration

Start: 2024-09-10End: 2025-07-01Updated: 2025-07-30

Phase 4

Pre-operative Vabysmo in Patients With Non-clearing Vitreous Hemorrhage Secondary to Proliferative Diabetic Retinopathy

Enrolling by invitationNCT06191094

University of Colorado, DenverDiabetic Retinopathy, Vitreous Hemorrhage Due to Diabetes Mellitus

Start: 2024-07-12End: 2028-01-01Target: 100Updated: 2026-06-01

Comparing Efficacy of 8-Week and 12-Week Faricimab Initial Follow-Up Treatment Intervals

RecruitingNCT06875245

Faculty Hospital Kralovske VinohradyWet Age-related Macular Degeneration

Start: 2023-03-31End: 2026-04-30Target: 100Updated: 2025-03-13